Dublin, June 19, 2025 (GLOBE NEWSWIRE) — The “Human Microbiome Market – Forecasts from 2025 to 2030” has been added to ResearchAndMarkets.com’s offering.
The global human microbiome market is projected to expand at a robust CAGR of 20.42%, reaching approximately US$2.38 billion by 2030, up from US$941.215 million in 2025.
This growth is primarily driven by escalating cases of lifestyle diseases, an increase in diarrheal infections, significant lifestyle shifts across populations, and a growing elderly demographic. The market also benefits from advancing technology in biomedical sciences and increased investment in research. Despite these positives, challenges such as insufficient awareness about prebiotics and probiotics and regulatory constraints pose significant obstacles for key market players.
Market Trends:
- Comprehensive Market Analysis: The global human microbiome market report offers an exhaustive examination of the sector, providing valuable insights and data-backed forecasts essential for strategic planning and understanding the market trajectory.
- Strategic Insights for Decision-makers: Updated regularly, the report provides crucial intelligence on market trends, emergent opportunities, and competitive dynamics. It delves into consumer demand across therapeutics, diagnostics, and probiotics, analyzing purchasing behaviors and key segments like healthcare providers, pharmaceutical companies, and consumers.
- Technological and Regulatory Exploration: The report investigates advancements such as next-generation sequencing and microbiome-based drug innovations, while also reviewing the regulatory landscape including policies on personalized medicine. This helps stakeholders strategize effectively in a rapidly advancing market.
Key Benefits of this Report:
- Insightful Analysis: Comprehensive insights covering major and emergent geographical markets, focusing on consumer segments, governmental policies, and industry verticals.
- Competitive Landscape: Analysis of strategies employed by key players to guide market entry and growth tactics.
- Market Drivers & Future Trends: An exploration of market dynamics and trends shaping the industry’s future.
- Actionable Recommendations: Leverage insights for strategic decisions, uncovering new business opportunities in a dynamic environment.
- Diverse Audience: Useful for startups, research institutions, consultants, SMEs, and large enterprises.
Report Coverage:
- Data from 2022 to 2024 with forecasts from 2025 to 2030
- Growth opportunities, challenges, supply chain outlook, regulatory framework, and trends
- Competitive positioning, strategies, and market share analysis
- Revenue growth forecast for segments and regions, including countries
Company Profiling: Strategies, Product Offerings, Financial Data, and Developments
- Seres Therapeutics
- Microbiome Therapeutics Innovation Group
- Vedanta Biosciences Inc.
- Metabiomics
- Ferring Pharmaceuticals
- Finch Therapeutics
- BiomeBank
- Biohm Technologies
- Resbiotic
- Immuron Limited
- Maat Pharma
Market Segmentation:
- Product Categories: Probiotic, Prebiotics, Supplements, Others
- Disease Categories: Diabetes, Autoimmune Disorder, Cancer, Obesity, Others
- Application Categories: Diagnostics, Therapeutics
- Regional Coverage: North America, South America, Europe, Middle East and Africa, Asia Pacific
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 148 |
| Forecast Period | 2025 – 2030 |
| Estimated Market Value (USD) in 2025 | $941.22 Million |
| Forecasted Market Value (USD) by 2030 | $2380 Million |
| Compound Annual Growth Rate | 20.4% |
| Regions Covered | Global |
For more information about this report visit https://www.researchandmarkets.com/r/jq6htj
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
